MUTYH-Associated Polyposis Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is MUTYH-Associated Polyposis?
MUTYH-Associated Polyposis (MAP) is an inherited colorectal polyposis syndrome caused by pathogenic variants in both copies of the MUTYH gene. The condition can lead to multiple adenomatous polyps in the colon and rectum and substantially increases the risk of colorectal cancer. MAP may also involve polyps or cancers in other organs, including the duodenum.
Some individuals may develop colorectal cancer even when they have relatively few colorectal polyps, making appropriate genetic assessment and surveillance important.
What is the Importance of Timely Treatment?
Timely diagnosis and surveillance are important because adenomatous polyps associated with MAP can gradually progress to colorectal cancer. Without appropriate surveillance, the lifetime risk of colorectal cancer can be very high. Regular colonoscopy allows doctors to identify and remove precancerous polyps before they progress. When the number or size of polyps becomes difficult to control endoscopically, colorectal surgery may be considered to reduce cancer risk.
What are the Common Symptoms of MUTYH-Associated Polyposis?
- Multiple adenomatous colorectal polyps
- Rectal bleeding or blood in the stool
- Abdominal pain or discomfort
- Bloating
- Changes in bowel habits
- Diarrhea
- Iron-deficiency anemia
- Unexplained weight loss
- Fatigue related to anemia or cancer
- Colorectal cancer in some individuals
- Duodenal or other gastrointestinal polyps
Causes and Risk Factors of MUTYH-Associated Polyposis
Causes
- MAP occurs because of pathogenic variants in both copies of the MUTYH gene, which repairs oxidative DNA damage. When both copies are affected, DNA repair may become less effective, allowing abnormal cells and adenomatous polyps to develop.
- MAP is inherited in an autosomal recessive pattern, meaning an affected individual generally inherits one pathogenic MUTYH variant from each parent.
Risk Factors
- Having pathogenic MUTYH variants in both gene copies
- Having parents who are carriers of a MUTYH pathogenic variant
- A family history of MAP or colorectal cancer
- A personal history of multiple adenomatous colorectal polyps
- Early-onset colorectal cancer
- Having a sibling with confirmed MAP
Latest Research and Technologies in the Treatment of MUTYH-Associated Polyposis in India
- Current management of MAP focuses on genetic diagnosis, regular colonoscopic surveillance, advanced polyp removal, and timely colorectal surgery when endoscopic management is no longer sufficient. Germline genetic testing, including multigene panels, can help distinguish MAP from other hereditary colorectal cancer syndromes. High-quality colonoscopy with polypectomy remains central to cancer prevention, while advanced endoscopic techniques can assist in managing suitable adenomas. For patients with extensive polyposis, minimally invasive colorectal surgery may be considered.
Treatment options for MUTYH-Associated Polyposis
Colonoscopic Surveillance and Polyp Removal: Regular high-quality colonoscopy allows doctors to identify and remove adenomatous polyps before they progress. Surveillance intervals are generally based on individual polyp burden and clinical findings.
Preventive Colorectal Surgery: Colectomy may be considered when the number, size, or distribution of polyps makes endoscopic management inadequate, or when colorectal cancer or significant symptoms are present.
Colectomy with Ileorectal Anastomosis: In selected patients, the colon may be removed while preserving the rectum, with the small intestine connected to the remaining rectum. Continued endoscopic surveillance of the rectum is required after surgery.
Proctocolectomy with Ileal Pouch-Anal Anastomosis: When there is extensive rectal polyposis, removal of both the colon and rectum may be considered, with creation of an ileal pouch to maintain bowel continuity.
Management of Upper Gastrointestinal and Other Manifestations: Upper GI endoscopy can identify gastric, duodenal, or periampullary adenomas. Selected lesions may be removed endoscopically, while thyroid or other abnormalities may require specialist evaluation.
- Clinical assessment:
- Colonoscopy and Polyp Evaluation: Colonoscopy helps identify and assess colorectal polyps based on their number, size, location, and appearance. Clinicians may excise suspicious or removable polyps for further evaluation.
- Histopathology and Genetic Testing: Doctors examine removed polyps under a microscope to confirm their type. Germline MUTYH genetic testing can confirm MAP, and multigene panels may be considered when other hereditary syndromes are suspected.
- Personal and Family History: Doctors review the patient's history of colorectal polyps or cancer and assess family history for hereditary colorectal conditions. This helps determine whether genetic counselling and family testing are needed.
- Blood Tests and Upper GI Evaluation: A complete blood count and iron studies may identify anemia caused by gastrointestinal blood loss. Upper gastrointestinal endoscopy can assess the stomach, duodenum, and ampulla for associated polyps.
- Genetic Counselling and Family Assessment: Genetic counselling helps patients understand MAP, its autosomal recessive inheritance, and implications for relatives. At-risk family members may be offered genetic testing and appropriate surveillance.
- Imaging Tests:
- Thyroid ultrasound: May be considered to evaluate or monitor thyroid abnormalities.
- CT or MRI: May be used when complications, colorectal cancer, or other associated tumors require further assessment.
- CT or MRI of the abdomen and pelvis: May be performed for staging when colorectal cancer is diagnosed.
- Other targeted imaging: May be recommended when symptoms or examination findings suggest disease outside the gastrointestinal tract.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support MUTYH-Associated Polyposis patients in India. These services include:
- Postoperative rehabilitation: Gradual physical activity and recovery support after abdominal or colorectal surgery.
- Nutritional support: Dietary guidance following colectomy or other gastrointestinal procedures.
- Bowel-function management: Education and support for changes in bowel habits following colorectal surgery.
- Cancer rehabilitation: Exercise, nutrition, fatigue management, and psychological support when colorectal cancer treatment is required.
- There is no medicine that corrects the inherited MUTYH variants or completely eliminates the need for colorectal surveillance. Medicines may also be used to manage symptoms, iron-deficiency anemia, postoperative complications, or colorectal cancer when present. Any chemoprevention or cancer-directed treatment should be selected by a specialist according to the patient's individual risk and clinical findings.
Instantly Connect with our Specialists
Hospitals for MUTYH-Associated Polyposis in India
Manipal Hospital, Dwarka
Delhi, India
Manipal Hospital Dwarka is a leading multi-super speciality tertiary care hospital offering world-class, affordable, and accessible healthcare. Backed by renowned doctors, advanced technology, and global standards in clinical care, the hospital provides comprehensive preventive, diagnostic, and therapeutic services for all age groups. With 380 beds, 13 modular OTs, 118 critical care beds, and 24/7 emergency services, it combines excellence in patient care with innovations like AI, telemedicine, remote monitoring, and EMR—striving to become a fully digital, paperless hospital setting new standards in modern healthcare.
Dr. Rela Institute and Medical Centre
Chennai, India
The mega-structure of RIMC serves as a hospital as well as an educational institute. Hence, it offers a huge array of medical services and facilities to cater to the needs of its patients.
Fertility Services - RIMC specializes in both male and female fertility and in procedures like IntraCytoplasmic Sperm Injection (ICSI), Uterine Transplants, Preimplantation genetics and Laser Assisted Hatching (LAH).
Anaesthesia and ICU - The ICU rooms in RIMC are equipped to serve the individual needs of every patient. They boast the largest liver transplant ICU in India and a specific ICU dedicated to pediatrics multi-organ transplants.
Radiology and Imaging Sciences - RIMC has the infrastructure to support high-quality scans including 128 Slice CT, Cardiac MRI, and 3 Tesla MRIs.
Blood Bank and Transfusion Medicine - RIMC has an active blood bank system with facilities dedicated to Blood Component Separation and Therapy. They use high-end technology like the Automated 1H500 Analyser and have a separate Therapeutic Apheresis Unit.
Advanced Endoscopy - Dr. Rela Institute and Medical Centre has one of the most advanced hospital facilities with an individual healthcare unit specifically dedicated to Endoscopy. Advanced procedures like Spyglass Cholangioscopy, Laser therapy, Endoscopic Ultrasound, Capsule Endoscopy, and special ERCP and EUS Suite.
Some of the other healthcare facilities, departments, and services offered by Dr. Rela Institute and Medical Healthcare are listed below:
- Orthopaedics
- Obstetrics and Gynaecology
- Reproductive Medicine
- Hepatology
- Cardiology
- Internal Medicine and Diabetology
- Advanced Paediatrics
- Ear Nose and Throat
- Emergency Medicine
- Interventional Radiology and Imaging Services
- Neonatology
- Neurology
- Liver Disease and Transplantation
- Gastroenterology
- Medical Oncology
- Nephrology
- Neonatology
- Pathology
- Ophthalmology
- Plastic and Reconstructive Surgery
- Radiation Oncology
- Pulmonary Medicine
- Urology
- Surgical Oncology
- Transfusion Medicine
Apart from these facilities, Dr. Rela Institute and Medical Centre also have a preventive health check lounge, 72 consultation suites, and 360 degrees including lab facilities specifically for outpatients.
Visit Dr. Rela Institute and Medical Centre in Chromepet, Chennai today and find the best care for you and your loved ones.
Global Health City
Chennai, India
The Hospital has world-class infrastructure with a capacity of over 1000 beds and much more-
- 265 Licensed beds
- 13 Operation Theatres
- 24*7 Cath Lab
- 24*7 available Blood Bank
- 24*7 Emergency Department
- 24*7 Open Pharmacy
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for MUTYH-Associated Polyposis Treatment?
- Experienced Gastrointestinal Specialists: India has gastroenterologists, colorectal surgeons, genetic specialists, oncologists, pathologists, and other professionals who can help manage hereditary colorectal polyposis.
- Advanced Endoscopic and Diagnostic Facilities: Specialised centres may provide high-quality colonoscopy, advanced polyp removal, upper GI endoscopy, genetic testing, pathology, and imaging for comprehensive disease assessment.
- Minimally Invasive Colorectal Surgery: Patients requiring surgery may have access to laparoscopic and robotic colorectal procedures, depending on their clinical condition and the expertise available at the selected centre.
- Multidisciplinary Cancer and Genetic Care: Patients can receive coordinated care involving gastroenterology, colorectal surgery, genetics, oncology, radiology, pathology, nutrition, and other specialities, as needed.
- International Patient Support: Many major Indian hospitals provide international patient services that can assist with specialist consultations, diagnostic coordination, treatment planning, accommodation, travel arrangements, and postoperative follow-up.